ArticleUrologic oncologyPublished
Sequential intravesical gemcitabine-docetaxel vs. bacillus Calmette-Guerin (BCG) in the treatment of non-muscle invasive bladder cancer: A preliminary cost-effectiveness analysis
Regional connection
Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Temple Health. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- Urologic oncology
- Published
- Topic
- Public health
- Subject terms
- Humans; Neoplasm Invasiveness; BCG Vaccine; Adjuvants, Immunologic; Administration, Intravesical; Aged; Medicare; United States; Urinary Bladder Neoplasms; Docetaxel; Gemcitabine; Non-Muscle Invasive Bladder Neoplasms
- PubMed ID
- 37127478
- Added to directory
- Source checked